Intravenous administration of azumolene to reverse malignant hyperthermia in swine

Journal of Veterinary Internal Medicine

Volumn 24, Issue 5, 2010, Pages 1224-1228

  do Carmo, P L ^a   Zapata Sudo, G ^a   Trachez, M M ^a   Antunes, F ^b   Guimaraes S E F ^c   Debom, R ^d   Rizzi, M D R ^d   Sudo, R T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^d Cristália Produtos Químicos e Farmacêuticos Ltda   (Brazil)

Author keywords

Anesthesia; Calcium; Pig; Skeletal muscle

Indexed keywords

ANALGESIC AGENT; AZUMOLENE; HALOTHANE; IMIDAZOLE DERIVATIVE; INHALATION ANESTHETIC AGENT; OXAZOLE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; FEMALE; GENETICS; GENOTYPE; MALE; MALIGNANT HYPERTHERMIA; SWINE; SWINE DISEASE;

ANALGESICS, NON-NARCOTIC; ANESTHETICS, INHALATION; ANIMALS; FEMALE; GENOTYPE; HALOTHANE; IMIDAZOLES; MALE; MALIGNANT HYPERTHERMIA; OXAZOLES; SWINE; SWINE DISEASES;

ANIMALIA; PIERIS BRASSICAE; SUIDAE;

EID: 77957900155     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0556.x     Document Type: Article

References (21)

1. Gronert GA. Malignant hyperthermia. In: Miller RD, ed. Anesthesia. New York: Churchill-Livingstone; 1986:1971-1994.
2. Fujii J, Otsu K, Zorzato F, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991;26:448-451.
3. Aleman M, Riehl I, Aldriige BM, et al. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Muscle Nerve 2004;30:356-365.
4. Roberts MC, Mickelson JR, Patterson EE, et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology 2001;95:716-725.
5. Robinson R, Carpenter D, Shaw MA, et al. Mutations in RYR1 in malignant hyperthermia and central core disease. Human Mutation 2006;27:977-989.
6. 2+ selective microelectrodes. Muscle Nerve 1986;9:85-86.
7. López JR, Álamo L, Caputo C, et al. Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia. Muscle Nerve 1985;8:355-358.
8. 2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophysical J 2004;87:3193-3204.
9. Murayama T, Oba T, Hara H, et al. Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia. Biochemical J 2007;402:349-357.
10. 2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia. J Biol Chem 2008;283:20813-20820.
11. Krause T, Gerbershagen MU, Fiege M, et al. Dantrolene-A review of its pharmacology, therapeutic use and new developments. Anaesthesia 2004;59:364-373.
12. White RL, Wessels FL, Schawan TJ, Ellis KO. 1-[[[5-(substituted phenyl)-2-oxazolyl]-methylene]amino]-2,4-imidazolidinediones, a new class of skeletal muscle relaxants. J Medic Chem 1987;30:263-266.
13. Sudo RT, Carmo PL, Trachez MM, Zapata-Sudo G. Effects of azumolene on normal and malignant hyperthermiasusceptible skeletal muscle. Basic Clin Pharmacol Toxicol 2008;102:308-316.
14. Zhao X, Weisleder N, Han X, et al. Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor. J Biol Chem 2006;281:33477-33486.
15. Band GO, Guimarães SEF, Lopes PS, et al. Relationship between the porcine stress syndrome gene and pork quality traits of F2 pigs resulting from divergent crosses. Genet Molec Biol 2005;28: 88-91.
16. Allen GC, Larach MG, Kunselman AR. The sensitivity and specifity of the caffeine-halotane contracture test: A report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS. Anesthesiology 1998;88:579-588.
17. Larach MG. Standardization of caffeine halothane muscle contracture test-North American Malignant Hyperthermia Group. Anesthesia and Analgesia 1989;69:511-515.
18. Dershwitz M, Sreter FA. Azumolene reverses episodes of malignant hyperthermia in susceptible swine. Anesthesia and Analgesia 1990;70:253-255.
19. Harrison GG. Control of the malignant hyperpirexic syndrome in MHS swine by dantrolene sodium. Brit Anaesthesia 1975;47:62-65.
20. 2+ sparks in skeletal muscle fibers. J Pharmacol Exper Therap 2005;314:94-102.
21. 2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine. Anesthesiology 1992;76:132-138.